CHICAGO (GenomeWeb) – Syapse, a maker of software to support precision oncology care, has entered the Asian market through a partnership with Seoul National University Hospital. A parallel deal with cloud IT company Megazone will allow the company to reach other potential customers in South Korea, Japan, and Vietnam.
Seoul National University Cancer Hospital will install the Syapse data-aggregation platform in its 28 centers across Korea, while Megazone, a major Amazon Web Services consulting partner in Asia, will provide IT support, the three entities said today. SNUH said oncologists should be able to make better treatment decisions with the help of Syapse's molecular analysis technology.
The South Korean health system is Syapse's first customer outside the US, the vendor said.
"SNUH has long been on the cutting edge in both cancer care and technology, and I’m thrilled to be partnering with them to help bring precision medicine to patients in South Korea," Syapse CEO Ken Tarkoff said in a statement.
"Through our precision medicine platform, we hope Seoul National University Hospital will provide a new standard for the evidence-based precision treatment of cancer," added SNUH Chief Information Officer Kyung Hwan Kim, a cardiothoracic surgeon.
San Francisco-based Syapse raised $30 million in new venture capital last fall to support such expansions.